Calcium intake and prostate cancer among African Americans: Effect modification by vitamin D receptor calcium absorption genotype

High dietary intake of calcium has been classified as a probable cause of prostate cancer, although the mechanism underlying the association between dietary calcium and prostate cancer risk is unclear. The vitamin D receptor (VDR) is a key regulator of calcium absorption. In the small intestine, VDR expression is regulated by the CDX‐2 transcription factor, which binds a polymorphic site in the VDR gene promoter. We examined VDR Cdx2 genotype and calcium intake, assessed by a food frequency questionnaire, in 533 African–American prostate cancer cases (256 with advanced stage at diagnosis, 277 with localized stage) and 250 African–American controls who participated in the California Collaborative Prostate Cancer Study. We examined the effects of genotype, calcium intake, and diet–gene interactions by conditional logistic regression. Compared with men in the lowest quartile of calcium intake, men in the highest quartile had an approximately twofold increased risk of localized and advanced prostate cancer (odds ratio [OR] = 2.20, 95% confidence interval [CI] = 1.40, 3.46), with a significant dose–response. Poor absorbers of calcium (VDR Cdx2 GG genotype) had a significantly lower risk of advanced prostate cancer (OR = 0.41, 95% CI = 0.19, 0.90). The gene–calcium interaction was statistically significant (p = 0.03). Among men with calcium intake below the median (680 mg/day), carriers of the G allele had an approximately 50% decreased risk compared with men with the AA genotype. These findings suggest a link between prostate cancer risk and high intestinal absorption of calcium. © 2012 American Society for Bone and Mineral Research

[1]  D. Fraser.  Exploration of possible mechanisms linking vitamin D status and dietary calcium to prostate cancer. , 2007, The British journal of nutrition.

[2]  J. Reginster,et al.  Acute biochemical variations induced by four different calcium salts in healthy male volunteers , 1993, Osteoporosis International.

[3]  J. Walters,et al.  Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[4]  E. Takeda,et al.  The Caudal‐Related Homeodomain Protein Cdx‐2 Regulates Vitamin D Receptor Gene Expression in the Small Intestine , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  S. Ingles,et al.  Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor , 2010, Cancer biology & therapy.

[6]  G. Schwartz.  Is serum calcium a biomarker of fatal prostate cancer? , 2009, Future oncology.

[7]  W. Willett,et al.  A Prospective Study of Calcium Intake and Incident and Fatal Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  G. Schwartz,et al.  A Prospective Study of Total and Ionized Serum Calcium and Fatal Prostate Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.

[9]  K. Bønaa,et al.  Determinants of serum calcium in men and women. The Tromsø study , 2004, European Journal of Epidemiology.

[10]  its Panel on Folate,et al.  STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .

[11]  Jian-Min Yuan,et al.  Calcium intake increases risk of prostate cancer among Singapore Chinese. , 2010, Cancer research.

[12]  O H Førde,et al.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. , 1990, American journal of epidemiology.

[13]  Ross J. Harris,et al.  Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis , 2011, Cancer Causes & Control.

[14]  Kari Stefansson,et al.  Multiple genetic loci for bone mineral density and fractures. , 2008, The New England journal of medicine.

[15]  R. Ziegler,et al.  Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. , 2005, The American journal of clinical nutrition.

[16]  Pär Stattin,et al.  Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries , 2004, International journal of cancer.

[17]  R. Strange,et al.  Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer , 2004, Environmental and molecular mutagenesis.

[18]  Arnold d'Alésio,et al.  Exons and functional regions of the human vitamin D receptor gene around and within the main 1a promoter are well conserved among mammals , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  G. Kristiansen,et al.  Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. , 2007, Human pathology.

[20]  M. Hakama,et al.  Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.

[21]  G. Schwartz.  Sunlight, Vitamin D and Prostate Cancer Epidemiology , 2011 .

[22]  B. Slepchenko,et al.  The role of passive transport in calcium absorption. , 2003, The Journal of nutrition.

[23]  G Block,et al.  A data-based approach to diet questionnaire design and testing. , 1986, American journal of epidemiology.

[24]  S. Ingles,et al.  Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. , 2005, Cancer research.

[25]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[26]  M. Pike,et al.  Estrogen-progestin replacement therapy and endometrial cancer. , 1998, Journal of the National Cancer Institute.

[27]  E. Takeda,et al.  The Polymorphism in the Caudal‐Related Homeodomain Protein Cdx‐2 Binding Element in the Human Vitamin D Receptor Gene , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  G. Schwartz,et al.  Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey , 2008, Cancer Epidemiology Biomarkers & Prevention.

[29]  C. Dang,et al.  Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. , 1998, Biochemical and biophysical research communications.

[30]  D. Feldman,et al.  Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. , 2011, Annual review of pharmacology and toxicology.

[31]  C. Mathieu,et al.  Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[32]  D. Spiegelman,et al.  Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25‐hydroxyvitamin D and 1,25‐dihydroxyvitamin D, and prostate cancer risk , 2007, The Prostate.

[33]  G. Schwartz.  VITAMIN D IN HEALTH AND DISEASE: Vitamin D and the Epidemiology of Prostate Cancer , 2005, Seminars in dialysis.

[34]  P. Gosset,et al.  Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry , 2009, Oncogene.

[35]  J. Hokanson,et al.  VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non–Hispanic White and Hispanic White Men , 2008, Clinical Cancer Research.

[36]  E. Giovannucci,et al.  Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer , 2009, Cancer Causes & Control.

[37]  K. Tucker,et al.  Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[38]  J. Eisman,et al.  Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.